SNX29 expression was associated with the clinical stage of several cancers, including BLCA (p = 0.013), KIRC (p = 0.00034), LUAD (p = 0.0044), testicular germ cell tumor (TGCT) (p = 0.031), and THCA (p = 0.011) (Fig. 4). This evidence concerns the gene SNX29 and cancer.